Akebia Therapeutics Inc
NASDAQ:AKBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
Mitsubishi HC Capital Inc
TSE:8593
|
JP |
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
IN |
|
F
|
Forvia SE
XMUN:FAU
|
FR |
|
Fortinet Inc
NASDAQ:FTNT
|
US |
|
Baytex Energy Corp
TSX:BTE
|
CA |
|
Becle SAB de CV
BMV:CUERVO
|
MX |
Wall St Price Targets
AKBA Price Targets Summary
Akebia Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AKBA is 4.28 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKBA's stock price target?
Price Target
4.28
USD
According to Wall Street analysts, the average 1-year price target for AKBA is 4.28 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Akebia Therapeutics Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Operating Income forecast for Akebia Therapeutics Inc?
Projected CAGR
34%
The compound annual growth rate for Operating Income over the next 8 years is 34%.
